You searched for: kemoterapiinduceret (Danska - Engelska)

behandling af symptomatisk kemoterapiinduceret anæmi hos cancerpatienter
treatment of symptomatic chemotherapy induced anaemia in cancer patients

til behandling af symptomatisk kemoterapiinduceret anæmi hos cancerpatienter
is treatment of symptomatic chemotherapy induced anaemia in cancer patients

mircera er ikke godkendt til behandling af patienter med kemoterapiinduceret anæmi (se pkt.
mircera is not approved for treatment of patients with chemotherapy induced anaemia (see section 4.1 and 4.4).

hånd- og fodsyndrom også kendt som hånd- og fodhudreaktion, palmoplantar erytrodysæstesi eller kemoterapiinduceret akralt erytem.
hand and foot syndrome also known as hand-foot skin reaction or palmar-plantar erythrodysesthesia or chemotherapy induced acral erythema.

hånd- og fodsyndrom også kendt som hånd- og fodhudreaktion, palmo-plantar erytrodysæstesi eller kemoterapiinduceret akralt erytem.
hand and foot syndrome (also known as hand-foot skin reaction or palmar-plantar erythrodysesthesia or chemotherapy induced acral erythema).

der blev foretaget en farmakokinetisk undersøgelse af patienter med kemoterapiinduceret anæmi behandlet med 6, 75 µg/kg darbepoetin alfa administreret sc hver tredje uge kombineret med kemoterapi, hvilket gjorde det
a pharmacokinetic study in patients with chemotherapy-induced anaemia treated with 6.75 µg/kg darbepoetin alfa administered sc every 3 weeks in combination with chemotherapy was conducted which allowed for full characterisation of the terminal half-life.

hånd- og fodsyndrom også kendt som hånd- og fodhudreaktion, palmo-plantar erythrodysæstesi eller kemoterapiinduceret acralt erytem).
hand and foot syndrome also known as hand-foot skin reaction or palmar-plantar erythrodysesthesia or chemotherapy induced acral erythema.

hand- foot syndrom (også kendt som hand- foot hudreaktion, palmo- plantar erythrodysæstesi eller kemoterapiinduceret acralt erytem).
hand-foot syndrome (also known as hand-foot skin reaction or palmar-plantar erythrodysesthesia or chemotherapy induced acral erythema).

dosering ivemend (115 mg) kan anvendes i stedet for aprepitant (125 mg) før kemoterapibehandling, på førstedagen af behandlingsregimet mod kemoterapiinduceret kvalme og opkastning (cinv) , og administreres som infusion over 15 minutter (se pkt.6. 6) .
posology ivemend (115 mg) may be substituted for aprepitant (125 mg) prior to chemotherapy, on day 1 only of the chemotherapy induced nausea and vomiting (cinv) regimen as an infusion administered over 15 minutes (see section 6.6) .